These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 23970333

  • 21. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH, Wong BC, Lin MC, Zhu GH, Kung HF, Jiang SH, Yang D, Lam SK.
    Oncogene; 2001 Nov 29; 20(55):8009-18. PubMed ID: 11753684
    [Abstract] [Full Text] [Related]

  • 22. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY, Kim GY, Kim ND, Jung JH, Kim SK, Kang HS, Choi YH.
    Oncol Rep; 2008 Feb 29; 19(2):517-26. PubMed ID: 18202802
    [Abstract] [Full Text] [Related]

  • 23. Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells.
    Kim R, Ohi Y, Inoue H, Toge T.
    Anticancer Res; 2000 Feb 29; 20(1A):439-44. PubMed ID: 10769693
    [Abstract] [Full Text] [Related]

  • 24. Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells.
    Moon JY, Cho M, Ahn KS, Cho SK.
    Nutr Cancer; 2013 Feb 29; 65(2):286-95. PubMed ID: 23441616
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of growth-inhibitory effect of cisplatin on human pancreatic cancer cells and status of p53 gene.
    Seki T, Ohba N, Makino R, Funatomi H, Mitamura K.
    Anticancer Res; 2001 Feb 29; 21(3B):1919-24. PubMed ID: 11497278
    [Abstract] [Full Text] [Related]

  • 26. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R, Tanabe K, Inoue H, Toge T.
    Int J Oncol; 2002 Mar 29; 20(3):549-55. PubMed ID: 11836567
    [Abstract] [Full Text] [Related]

  • 27. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
    Jones NA, Turner J, McIlwrath AJ, Brown R, Dive C.
    Mol Pharmacol; 1998 May 29; 53(5):819-26. PubMed ID: 9584207
    [Abstract] [Full Text] [Related]

  • 28. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z, Zeng Q, Zhang B, Liu H, Wang W.
    Biochimie; 2014 Dec 29; 107 Pt B():257-62. PubMed ID: 25220870
    [Abstract] [Full Text] [Related]

  • 29. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
    Su J, Xu Y, Zhou L, Yu HM, Kang JS, Liu N, Quan CS, Sun LK.
    Anat Rec (Hoboken); 2013 Apr 29; 296(4):595-603. PubMed ID: 23408563
    [Abstract] [Full Text] [Related]

  • 30. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
    Toyozumi Y, Arima N, Izumaru S, Kato S, Morimatsu M, Nakashima T.
    Int J Oncol; 2004 Sep 29; 25(3):721-8. PubMed ID: 15289875
    [Abstract] [Full Text] [Related]

  • 31. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata.
    Bhushan S, Malik F, Kumar A, Isher HK, Kaur IP, Taneja SC, Singh J.
    Mol Carcinog; 2009 Dec 29; 48(12):1093-108. PubMed ID: 19544329
    [Abstract] [Full Text] [Related]

  • 32. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S, Olivero M, Corà D, Di Renzo MF.
    Eur J Cancer; 2013 Mar 29; 49(4):964-73. PubMed ID: 23079474
    [Abstract] [Full Text] [Related]

  • 33. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 34. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL, Ling YF, Lai MD.
    Anticancer Res; 2000 Feb 15; 20(1A):329-36. PubMed ID: 10769676
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J, Kirchner B, Eicher C, Warmann SW, Seitz G, Fuchs J, Armeanu-Ebinger S.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1089-95. PubMed ID: 20680965
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivo.
    Zhang LL, Zhang J, Shen L, Xu XM, Yu HG.
    Mol Med Rep; 2013 May 01; 7(5):1387-90. PubMed ID: 23546174
    [Abstract] [Full Text] [Related]

  • 37. DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway.
    Fang Y, Chai Z, Wang D, Kuang T, Wu W, Lou W.
    Mol Cell Biochem; 2015 Jan 01; 399(1-2):269-78. PubMed ID: 25348361
    [Abstract] [Full Text] [Related]

  • 38. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Wang R, Ma L, Weng D, Yao J, Liu X, Jin F.
    Oncol Rep; 2016 May 01; 35(5):3075-83. PubMed ID: 26987028
    [Abstract] [Full Text] [Related]

  • 39. Anthocyanins Isolated from Vitis coignetiae Pulliat Enhances Cisplatin Sensitivity in MCF-7 Human Breast Cancer Cells through Inhibition of Akt and NF-κB Activation.
    Paramanantham A, Kim MJ, Jung EJ, Kim HJ, Chang SH, Jung JM, Hong SC, Shin SC, Kim GS, Lee WS.
    Molecules; 2020 Aug 09; 25(16):. PubMed ID: 32784919
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.